Today: 7 February 2026
Subscribe

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

Intelligent Bio Solutions shares fell 12.1% to $8.38 in late morning trading after announcing a $10 million private placement with two tranches of warrants. The deal, priced at $4.35 per share and warrant, follows a manufacturing partnership with Syrma Johari MedTech aimed at cutting costs and boosting margins ahead of a planned 2026 U.S. launch.
2 January 2026
··
Fermi (FRMI) stock jumps about 14% today as traders track lawsuit probes and next Project Matador update

Fermi (FRMI) stock jumps about 14% today as traders track lawsuit probes and next Project Matador update

Fermi Inc (FRMI.O) shares jumped 14% to $9.12 in midday trading Friday, with volume over 4.4 million. The rebound follows a 34% plunge last month after a $150 million construction funding deal was terminated. Shareholder law firms announced investigations into potential investor claims on Jan. 1. Fermi is seeking tenants for its Texas data-center project after denying links to Amazon.
2 January 2026
··
SoFi stock jumps today after earnings date update; what SOFI investors watch next

SoFi stock jumps today after earnings date update; what SOFI investors watch next

SoFi shares rose 3.7% to $27.16 in midday New York trading Friday after the company set Jan. 30 for its fourth-quarter and full-year results. About 25.5 million shares traded as investors positioned for updates on loan growth and credit trends. The stock moved between $25.80 and $27.17 during the session. Broader U.S. markets opened 2026 higher, led by large-cap tech gains.
2 January 2026
··
Bitmine Immersion (BMNR) slips as Tom Lee urges shareholders to back 50 billion authorized-share plan

Bitmine Immersion (BMNR) slips as Tom Lee urges shareholders to back 50 billion authorized-share plan

Bitmine Immersion Technologies shares fell about 2% to $27.15 Friday after the company filed materials urging shareholders to approve raising its authorized share count to 50 billion. Chairman Tom Lee said the move would enable stock splits and future capital activity. The annual meeting and vote are set for January 15. Crypto-linked stocks, including Coinbase and Marathon Digital, also traded lower.
2 January 2026
··
Salesforce (CRM) stock slides 3% today, weighing on Dow as traders eye jobs data and Fed path

Salesforce (CRM) stock slides 3% today, weighing on Dow as traders eye jobs data and Fed path

Salesforce shares dropped 3.3% to $256.11 in late-morning trading Friday, weighing on the Dow after a volatile start to 2026. The stock traded between $252.49 and $267.00 as investors repositioned ahead of U.S. jobs and inflation data next week. Tech stocks broadly rebounded, with the S&P 500 tech index up 1.2%. Salesforce is set to pay a $0.416 dividend on Jan. 8.
2 January 2026
···
Ford stock slips in premarket as Tesla delivery miss revives EV demand worries

Ford stock slips in premarket as Tesla delivery miss revives EV demand worries

Ford shares fell 0.7% to $13.12 in premarket trading Friday, following weaker-than-expected Tesla deliveries and ongoing concerns about U.S. electric vehicle demand after the federal tax credit ended. General Motors dropped 1.2%, Tesla slid 1.1%, while Rivian rose 0.7%. Tesla reported 418,227 deliveries for the quarter, missing estimates. Investors are watching economic data and interest-rate signals as 2026 trading begins.
2 January 2026
······
BitMine Immersion (BMNR) stock jumps as Tom Lee presses vote to lift authorized shares to 50 billion

BitMine Immersion (BMNR) stock jumps as Tom Lee presses vote to lift authorized shares to 50 billion

BitMine Immersion shares jumped 11.3% to $30.22 after the company filed materials urging shareholders to approve raising authorized shares to 50 billion from 500 million. Chairman Tom Lee cited potential stock splits and capital market moves in a video message. The vote is set for later this month. Crypto-linked stocks and tokens, including ether and bitcoin, also traded higher.
2 January 2026
··
Intuit stock slides as co-founder Scott Cook sells about $101 million in shares, filings show

Intuit stock slides as co-founder Scott Cook sells about $101 million in shares, filings show

Intuit co-founder Scott Cook sold 150,000 shares for about $100.9 million at the end of 2025, according to SEC filings. The sales, made through his family trust under a pre-set plan, were priced between $669 and $678 a share. Intuit stock fell about 5% to $629.50 in late morning trading Friday. Cook’s trust held roughly 5.67 million shares after the transactions.
2 January 2026
·
D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

D-Wave Quantum (QBTS) stock rises to start 2026 as traders eye CES and key U.S. data

D-Wave Quantum shares rose about 3% to $26.95 by midday Friday, trading between $25.44 and $27.64 on heavy volume. The move followed gains in other quantum-computing stocks as tech led early 2026 market strength. Investors are watching D-Wave’s CES Foundry appearance Jan. 7-8 and the U.S. jobs report next week for further direction.
2 January 2026
·····
TSX’s blockbuster 2025 sets up 2026 — and this 8.7%-yield REIT is back in focus

TSX’s blockbuster 2025 sets up 2026 — and this 8.7%-yield REIT is back in focus

Canada’s S&P/TSX Composite Index surged nearly 29% in 2025, its strongest annual gain since 2009, before closing the year at 31,712.76, down 0.4% on the final day. Firm Capital Property Trust drew renewed interest with an 8.6% distribution yield, trading near C$6.10 per unit. Investors are watching whether the rally in materials and precious-metals stocks can continue into 2026.
2 January 2026
·
Pfizer stock slips before the bell as 2026 drug price hikes put PFE back in focus

Pfizer stock slips before the bell as 2026 drug price hikes put PFE back in focus

Pfizer shares fell 0.4% to $24.90 in premarket trading Friday after Reuters reported the company plans to raise U.S. list prices on about 80 medicines in 2026, including a 15% hike for COVID-19 vaccine Comirnaty. The moves come as drugmakers face pressure from the Trump administration to lower prices and as investors await Pfizer’s February 3 results update.
2 January 2026
··
Adobe stock drops more than 4% as new bull case says AI fears are overdone

Adobe stock drops more than 4% as new bull case says AI fears are overdone

Adobe shares fell 4.4% Friday morning amid a broader software sector decline, trading near $334 with a market value of about $140 billion. Investors remain focused on whether generative AI will threaten or boost demand for Adobe’s paid creative tools. Salesforce, Autodesk, and Microsoft also traded lower. Adobe’s 52-week range spans $312 to $466, reflecting volatility tied to AI’s impact on its business model.
2 January 2026
··
Stock market today: S&P 500, Nasdaq start 2026 higher as tech rebounds; Intuit sinks on co-founder sale

Stock market today: S&P 500, Nasdaq start 2026 higher as tech rebounds; Intuit sinks on co-founder sale

U.S. stocks opened 2026 higher, with the S&P 500 up 0.38% and the Nasdaq gaining 0.75% by midmorning, led by large technology shares. Intuit dropped 5.3% after a filing showed co-founder Scott Cook sold $50 million in stock. Nvidia and Broadcom rose, while furniture retailers gained after President Trump delayed some tariffs. European and Asian markets also advanced; oil fell over 1%.
2 January 2026
······
1 … 609 610 611 612 613 … 1,634

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop